The case for HPV immunization.
HPV4 is now available for boys, and a second vaccine to protect against HPV-associated cancer has been approved. Should you be using these vaccines in your practice?
Campos-Outcalt
Doug
D
Department of Family and Community Medicine, University of Arizona College of Medicine, Phoenix, AZ, USA. dougco@u.arizona.edu
D000293:Adolescent; D000328:Adult; D001005:Anus Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D001291:Attitude of Health Personnel; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D005260:Female; D052689:Gammapapillomavirus / Q000276:immunology; D006801:Humans; D008297:Male; D030361:Papillomavirus Infections / Q000150:complications / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000009:adverse effects; D012449:Safety; D012955:Societies, Medical; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D014611:Vaccination; D014944:World Health Organization; D055815:Young Adult
D053918:Papillomavirus Vaccines